February 26, 2020 / 3:39 PM / a month ago

BRIEF-Novavax Advances Development Of Novel COVID-19 Vaccine

Feb 26 (Reuters) - Novavax Inc:

* NOVAVAX ADVANCES DEVELOPMENT OF NOVEL COVID-19 VACCINE

* NOVAVAX INC - PHASE 1 CLINICAL TRIAL PLANNED FOR LATE SPRING

* NOVAVAX INC - EXPECTS TO UTILIZE ITS PROPRIETARY MATRIX-M ADJUVANT WITH ITS COVID-19 VACCINE CANDIDATE TO ENHANCE IMMUNE RESPONSES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below